Lamotrigine Extended Release
Lamotrigine
0 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Lamotrigine
Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Par Health USA, LLC | unknown | 3 | EXITED 2026 |
Shortages, recalls, and registration changes attached to this drug concept.
Lamotrigine Tablet, Extended Release — reported in shortage by Par Health, Inc.. Therapeutic category: Neurology.
Lamotrigine Tablet, Extended Release — reported in shortage by Par Health, Inc.. Therapeutic category: Neurology.
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC